DLX1-NCS1-MYC轴驱动肺腺癌的瘤发生和进展
Bozhi Zhang1, Hongyi Huang2, Xun Zou3
1Department of Ultrasound Diagnosis, Bethune International Peace Hospital, Shijiazhuang 050082, Hebei Province, China.
概括
我们发现DLX1是肺腺癌 (LUAD) 进展的关键驱动因素. DLX1通过调节NCS1-MYC通路来促进LUAD,影响细胞生长和患者生存.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 肺腺癌 (LUAD) 是癌症死亡的主要原因.
- 推动LUAD进展的分子机制尚未完全理解.
研究的目的:
- 为了确定肺腺癌的新型转录调节剂.
- 阐明DLX1在LUAD中的功能作用和分子机制.
主要方法:
- 整合性转录基因分析 (RNA序列,微阵列) 的LUAD组织.
- 功能性研究包括基因沉默,体外测试 (增殖,入侵,殖民地形成) 和体内瘤抑制.
- 使用基因组丰富分析 (GSEA),染色体免疫沉 (ChIP) 和光酶试验的机理研究.
主要成果:
- 在LUAD中DLX1显著过度表达,并与晚期,TP53突变和生存率低下有关.
- DLX1沉默抑制了LUAD细胞的增殖,入侵和瘤生长.
- DLX1直接激活NCS1转录,这反过来反过来调节c-MYC.
- 在LUAD中,DLX1-NCS1-MYC轴被确定为关键瘤网络.
结论:
- DLX1是肺腺癌中一个关键的瘤转录因子.
- DLX1-NCS1-MYC信号轴代表了LUAD的潜在治疗目标.
相关概念视频
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Induced Pluripotent Stem Cells
4.4K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
4.4K
Tumor Progression
6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K
lncRNA - Long Non-coding RNAs
9.0K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.0K
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
Adaptive Mechanisms in Cancer Cells
5.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K


